C
Cel-Sci Corp D
D
CVM
5.36500
USD
0.17
(3.17%)
مفتوح الان
حجم التداول
100
الربح لكل سهم
-9
العائد الربحي
-
P/E
-1
حجم السوق
43,006,028
الأخبار المقالات
العنوان: Cel/Sci Corp
القطاع: Healthcare
الصناعة: Biotechnology
CEL-SCI Corp is a late clinical-stage biotechnology company dedicated to research and development directed at improving the treatment of cancer and other diseases by using the immune system, the body's natural defense system. The company is focused on the development of the following product candidates and technologies: 1) Multikine, an investigational Phase 3 immunotherapy under development for the potential treatment of certain head and neck cancers; 2) LEAPS (Ligand Epitope Antigen Presentation System) technology, for the potential treatment of rheumatoid arthritis.